These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 19910122)
1. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Bishayee A; Politis T; Darvesh AS Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122 [TBL] [Abstract][Full Text] [Related]
2. Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance. Bishayee A; Thoppil RJ; Waghray A; Kruse JA; Novotny NA; Darvesh AS Curr Cancer Drug Targets; 2012 Nov; 12(9):1191-232. PubMed ID: 22873222 [TBL] [Abstract][Full Text] [Related]
3. Selenium in the prevention and treatment of hepatocellular carcinoma. Darvesh AS; Bishayee A Anticancer Agents Med Chem; 2010 May; 10(4):338-45. PubMed ID: 20380634 [TBL] [Abstract][Full Text] [Related]
4. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer. Darvesh AS; Bishayee A Nutr Cancer; 2013; 65(3):329-44. PubMed ID: 23530632 [TBL] [Abstract][Full Text] [Related]
5. Curcumin and liver cancer: a review. Darvesh AS; Aggarwal BB; Bishayee A Curr Pharm Biotechnol; 2012 Jan; 13(1):218-28. PubMed ID: 21466422 [TBL] [Abstract][Full Text] [Related]
6. Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Luther DJ; Ohanyan V; Shamhart PE; Hodnichak CM; Sisakian H; Booth TD; Meszaros JG; Bishayee A Invest New Drugs; 2011 Apr; 29(2):380-91. PubMed ID: 19812893 [TBL] [Abstract][Full Text] [Related]
7. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Aziz MH; Kumar R; Ahmad N Int J Oncol; 2003 Jul; 23(1):17-28. PubMed ID: 12792772 [TBL] [Abstract][Full Text] [Related]
8. Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis. Mbimba T; Awale P; Bhatia D; Geldenhuys WJ; Darvesh AS; Carroll RT; Bishayee A Curr Pharm Biotechnol; 2012 Jan; 13(1):229-34. PubMed ID: 21466437 [TBL] [Abstract][Full Text] [Related]
9. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review. Mastron JK; Siveen KS; Sethi G; Bishayee A Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021 [TBL] [Abstract][Full Text] [Related]
10. Has selenium a chemopreventive effect on hepatocellular carcinoma? Costantini S; Lepore MG; Castello G; Colonna G Mini Rev Med Chem; 2011 Jun; 11(7):599-610. PubMed ID: 21699491 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats. Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372 [TBL] [Abstract][Full Text] [Related]
12. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma. Seren S; Mutchnick M; Hutchinson D; Harmanci O; Bayraktar Y; Mutchnick S; Sahin K; Kucuk O Nutr Cancer; 2008; 60(6):729-35. PubMed ID: 19005972 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism. Yu HB; Zhang HF; Zhang X; Li DY; Xue HZ; Pan CE; Zhao SH Hepatogastroenterology; 2010; 57(102-103):1241-6. PubMed ID: 21410066 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Bishayee A; Dhir N Chem Biol Interact; 2009 May; 179(2-3):131-44. PubMed ID: 19073162 [TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy. Bishayee A; Darvesh AS Curr Cancer Drug Targets; 2012 Nov; 12(9):1095-118. PubMed ID: 22873221 [TBL] [Abstract][Full Text] [Related]
16. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Mann CD; Neal CP; Garcea G; Manson MM; Dennison AR; Berry DP Eur J Cancer Prev; 2009 Feb; 18(1):13-25. PubMed ID: 19077560 [TBL] [Abstract][Full Text] [Related]
17. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323 [TBL] [Abstract][Full Text] [Related]
18. The potential of resveratrol against human gliomas. Gagliano N; Aldini G; Colombo G; Rossi R; Colombo R; Gioia M; Milzani A; Dalle-Donne I Anticancer Drugs; 2010 Feb; 21(2):140-50. PubMed ID: 20010425 [TBL] [Abstract][Full Text] [Related]
19. Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. Bishayee A; Waghray A; Barnes KF; Mbimba T; Bhatia D; Chatterjee M; Darvesh AS Pharm Res; 2010 Jun; 27(6):1080-91. PubMed ID: 20405173 [TBL] [Abstract][Full Text] [Related]
20. Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review. Baby J; Devan AR; Kumar AR; Gorantla JN; Nair B; Aishwarya TS; Nath LR J Food Biochem; 2021 Jul; 45(7):e13761. PubMed ID: 34028054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]